CME Group EBITDA 2010-2024 | CME

CME Group EBITDA for the quarter ending September 30, 2024 was $1.108B, a 21.97% increase year-over-year.

  • CME Group 2023 EBITDA was 3.788B, a 12.13% increase from 2022.
  • CME Group 2022 EBITDA was 3.379B, a 11.48% increase from 2021.
  • CME Group 2021 EBITDA was 3.031B, a 2.3% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

CME Group EBITDA 2010-2024 | CME

  • CME Group 2023 EBITDA was 3.788B, a 12.13% increase from 2022.
  • CME Group 2022 EBITDA was 3.379B, a 11.48% increase from 2021.
  • CME Group 2021 EBITDA was 3.031B, a 2.3% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Intercontinental Exchange (ICE)$90.7B
Nasdaq (NDAQ)$46.1B
MarketAxess Holdings (MKTX)$10.1B
OTC Markets Group (OTCM)$640M